What Research Says About 5-MeO-DMT, Depression, and Anxiety

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a short-acting psychedelic compound found in some plants and animal secretions and can also be produced synthetically.

A 2019 study examined people who had used 5-MeO-DMT in a structured naturalistic group setting. Researchers were interested in whether participants with previously diagnosed depression or anxiety reported changes in those conditions after their experiences.

The group setting included procedures for preparation, administration, support during the experience, and follow-up. The study observed experiences that had already occurred rather than providing 5-MeO-DMT as part of a clinical trial.

5-MeO-DMT interacts with the brain's serotonin system, including serotonin receptors involved in mood, perception, and consciousness.

This particular study was designed to examine participants' reported outcomes rather than determine the biological mechanisms responsible for them.

Researchers instead explored whether reported improvements in depression and anxiety were associated with characteristics of the psychedelic experience, including its personal meaning, spiritual significance, and the intensity of mystical or challenging effects.

5-MeO-DMT can produce rapid and intense changes in consciousness.

Participants in psychedelic research have reported experiences involving:

Experiences vary widely between individuals. This study specifically measured both mystical-type and challenging aspects of participants' experiences.

Participants in this study were not receiving 5-MeO-DMT as a treatment for depression or anxiety.

The researchers described improvements in these conditions as unintended because participants used 5-MeO-DMT primarily for other reasons within a structured group setting.

Researchers are interested in studying 5-MeO-DMT further because preliminary observational research has identified possible associations with changes in:

These findings remain preliminary and require controlled clinical research.

Researchers surveyed 362 adults who had previously used 5-MeO-DMT in a structured group setting.

Among participants, 41% reported having been diagnosed with depression and 48% reported having been diagnosed with anxiety.

Among those reporting depression:

Among those reporting anxiety:

Greater reported improvements were associated with more intense mystical-type experiences and greater ratings of personal meaning and spiritual significance.

The intensity of challenging physical or psychological experiences was not associated with whether participants reported improvements in depression or anxiety.

These results were based on participants recalling and evaluating their own experiences. The study did not include a placebo group, clinical diagnosis by the researchers, or measurements taken before and after 5-MeO-DMT administration.

This study was not designed to establish the safety of 5-MeO-DMT or determine whether it is an effective treatment for depression or anxiety.

Important limitations include:

The structured group environment may also have influenced participants' experiences and outcomes.

5-MeO-DMT can produce intense psychological and physical effects, and research into its safety, contraindications, medication interactions, and effects in people with psychiatric conditions remains developing.

In this naturalistic survey, most participants who reported having depression or anxiety also reported improvements in those conditions following 5-MeO-DMT use.

Greater reported improvements were associated with experiences participants rated as more personally meaningful, spiritually significant, or mystical.

The study provides an early reason to investigate 5-MeO-DMT and mental health outcomes more closely. Its observational and retrospective design cannot determine whether 5-MeO-DMT caused the reported improvements. Controlled prospective studies are needed to better understand its safety and potential effects.

🔎 Research Links:

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is

associated with unintended improvements in depression and anxiety

The article was already fairly close to your Public Library format, but I made several changes to bring it back in line with our established guidelines: accessible language, evidence-first framing, short readable paragraphs, no treatment claims, clear separation between findings and unknowns, and the standard section structure.

I also fixed the Research Links section. Zac had accidentally split the study title into two separate links pointing to the same paper, and the URL contained a utm_source=chatgpt.com tracking parameter. I removed that.